From: Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
 | N | Mean | SD | U Mann-hitney | p | N | Mean | SD | U Mann-Whitney | p |
---|---|---|---|---|---|---|---|---|---|---|
 | TAS (mM) | GSH (μM) | ||||||||
Control group | 94 | 1.26 | 0.05 | Â | Â | 93 | 394.11 | 15.90 | Â | Â |
SCHb | 49 | 0.91 | 0.04 | 1193.50 | < 0.001 | 43 | 308.34 | 20.06 | 1317.50 | 0.005 |
PNOS-a | 25 | 0.99 | 0.09 | 622 | 0.002 | 21 | 327.62 | 29.21 | 555 | 0.195 |
BIPd | 18 | 0.88 | 0.06 | 290.50 | 0.001 | 17 | 347.44 | 24.15 | 530.50 | 0.606 |
DEPc | 10 | 1.16 | 0.14 | 232.50 | 0.501 | 9 | 350.27 | 45.23 | 245.50 | 0.841 |
 | LOOH (μM) | cGPX (mU/mL) | ||||||||
Control group | 82 | 6.17 | 0.47 | Â | Â | 93 | 912.96 | 59.93 | Â | Â |
SCHb | 33 | 10.06 | 2.50 | 1431 | 0.161 | 43 | 1068.37 | 61.63 | 2283.50 | 0.015 |
PNOS-a | 17 | 6.03 | 0.87 | 641 | 0.856 | 21 | 620.73 | 135.46 | 823.50 | 0.734 |
BIPd | 15 | 10.88 | 1.58 | 713.50 | 0.004 | 17 | 1142.08 | 112.88 | 831 | 0.031 |
DEPc | 9 | 8.82 | 1.60 | 328.50 | 0.083 | 9 | 728.812 | 80.62 | 228 | 0.447 |